title: Use of neoadjuvant chemotherapy for muscle-invasive bladder cancer is low among major European centres: results of a feasibility questionnaire.
authors.forename: Maximilian
authors.initials: M
authors.lastname: Burger
authors.forename: Peter
authors.initials: P
authors.lastname: Mulders
authors.forename: Wim
authors.initials: W
authors.lastname: Witjes
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017322:Clinical Trials, Phase II as Topic; D015653:Cystectomy; D018572:Disease-Free Survival; D005060:Europe; D005260:Female; D006801:Humans; D008297:Male; D020360:Neoadjuvant Therapy / Q000706:statistics & numerical data*; D011795:Surveys and Questionnaires; D015996:Survival Rate; D016896:Treatment Outcome; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000601:surgery
chemical_list: D000970:Antineoplastic Agents